Continuity for Trophos
12.07.2012 - In June, French Trophos SA appointed Christine Placet as its chief executive officer. She becomes CEO under a previously defined internal succession plan designed to provide continuity for Trophos, to bring the company's ongoing programmess to a successful conclusion and to seek strategic partnerships for its advanced clinical development drug candidates.
From 2004, Placet was CFO of the clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology. She has over 25 years' experience in a variety of areas of finance and business management. Prior to joining Trophos, she was CFO in a number of growing companies and start-ups in various industries, and worked as an auditor for eight years for Ernst & Young. She has a graduate diploma in financial accounting (DESCF) and a business school diploma from Sup de Co Marseille (DESCAF). Damian Marron, previously CEO, has moved to the biopharmaceutical Company Cytheris SA.